Proteomics

Dataset Information

0

Drug-tolerant cell-derived exosomes regulate proteasome inhibitor resistance pathways in MLL leukemias


ABSTRACT: The interplay between cancer cells and microenvironment can influence treatment response and plays a key role in the emergence of drug resistance. Rapidly acquired resistance prevents proteasome inhibitors (PIs) therapies from achieving stable and complete responses. Investigating the underlying mechanisms and developing effective strategies against PI resistance are highly desired in the clinic. Here we uncovered that PI resistance was reversible in MLL leukemia, which consistent with the finding that patients could regain sensitivity to PIs after a drug holiday. Exosomes derived from drug-tolerant cells could transmit PI resistance to sensitive cells via facilitating cell cycle arrest and stemness pathway in MLL leukemia cells. Furthermore, TieDIE algorithm integration analysis of transcriptome and proteome datasets identified candidate exosomal proteins, providing potential therapeutic targets for treating refractory MLL leukemia. Therefore, exosomal regulatory proteins may serve as a predictor and a potential therapeutic target for PI resistance, and inhibiting the secretion of exosomes is a promising strategy for restoring PI resistance in vivo, which provides a paradigm and may also be applied for the treatment of other cancers resulting from chemotherapy relapse.

OTHER RELATED OMICS DATASETS IN: GSE134879

INSTRUMENT(S): LTQ Orbitrap

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): B Cell, Cell Culture

DISEASE(S): Acute Leukemia

SUBMITTER: Zhi Qiao  

LAB HEAD: Han Liu

PROVIDER: PXD014711 | Pride | 2020-05-27

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
RS411-Nexo-1.raw Raw
RS411-Nexo-2.raw Raw
RS411-Nexo-3.raw Raw
RS411-Rexo-1.raw Raw
RS411-Rexo-2.raw Raw
Items per page:
1 - 5 of 7
altmetric image

Publications

Exosomes mediate intercellular transfer of non-autonomous tolerance to proteasome inhibitors in mixed-lineage leukemia.

Ge Maolin M   Qiao Zhi Z   Kong Yan Y   Lu Hui H   Liu Han H  

Cancer science 20200310 4


Proteasome inhibitors significantly improve cancer outcomes, but their use is eventually followed by proteasome inhibitor resistance and relapse. Current understanding of proteasome inhibitor resistance is limited to cell-autonomous mechanisms; whether non-autonomous mechanisms can be implicated in the development of proteasome inhibitor resistance is unclear. Here, we show that proteasome inhibitor tolerance can be transmitted non-autonomously through exosome-mediated intercellular interactions  ...[more]

Similar Datasets

2020-04-22 | GSE134879 | GEO
2020-09-21 | GSE138177 | GEO
2021-02-24 | GSE136725 | GEO
2013-05-01 | E-GEOD-42282 | biostudies-arrayexpress
2016-11-03 | E-MTAB-4166 | biostudies-arrayexpress
2022-02-16 | PXD028779 | Pride
2015-08-31 | E-GEOD-70994 | biostudies-arrayexpress
2015-08-31 | E-GEOD-70995 | biostudies-arrayexpress
2024-10-24 | PXD019283 | Pride
2024-09-15 | GSE184310 | GEO